TENX Tenax Therapeutics, Inc. Stock Quote

TENX [NASD]

Index	-	P/E	-	EPS (ttm)	-3.96	Insider Own	4.40%	Shs Outstand	14.97M	Perf Week	0.00%
Market Cap	31.70M	Forward P/E	-	EPS next Y	-0.11	Insider Trans	0.00%	Shs Float	11.59M	Perf Month	8.99%
Income	-9.90M	PEG	-	EPS next Q	-0.21	Inst Own	22.80%	Short Float	3.33%	Perf Quarter	-23.70%
Sales	-	P/S	-	EPS this Y	2.00%	Inst Trans	0.75%	Short Ratio	0.29	Perf Half Y	108.08%
Book/sh	5.18	P/B	0.40	EPS next Y	81.70%	ROA	-145.00%	Target Price	-	Perf Year	181.04%
Cash/sh	0.44	P/C	4.66	EPS next 5Y	-	ROE	-213.30%	52W Range	0.69 - 3.68	Perf YTD	10.75%
Dividend	-	P/FCF	-	EPS past 5Y	28.60%	ROI	-	52W High	-44.02%	Beta	2.40
Dividend %	-	Quick Ratio	3.20	Sales past 5Y	-	Gross Margin	-	52W Low	198.55%	ATR	0.16
Employees	9	Current Ratio	3.20	Sales Q/Q	-	Oper. Margin	-	RSI (14)	52.59	Volatility	8.38% 7.09%
Optionable	No	Debt/Eq	0.04	EPS Q/Q	-666.30%	Profit Margin	-	Rel Volume	0.03	Prev Close	2.01
Shortable	Yes	LT Debt/Eq	0.02	Earnings	-	Payout	-	Avg Volume	1.34M	Price	2.06
Recom	2.00	SMA20	4.82%	SMA50	2.16%	SMA200	23.56%	Volume	44,391	Change	2.49%

May-18-17

Upgrade

Ladenburg Thalmann

Neutral → Buy

Dec-16-14

Initiated

MLV & Co

Buy

Nov-18-14

Initiated

WallachBeth

Buy

$12

Apr-14-21 07:45AM	TENX: HELP Results & New Asset to Boot Zacks Small Cap Research
Apr-09-21 11:38AM	Tenax Rises on Progress With Hypertension Treatment TheStreet.com +16.85%
08:00AM	Tenax Announces Publication Titled "Levosimendan Improves Hemodynamics and Exercise Tolerance in PH-HFpEF: Results of the Randomized Placebo-Controlled HELP Trial " Business Wire
Apr-07-21 04:45PM	Tenax Therapeutics Announces Continuation of Board Refreshment Program as Three Long-Serving Directors Volunteer to Not Stand for Re-Election at the Upcoming 2021 Annual Meeting of Stockholders Business Wire
Mar-31-21 04:45PM	Tenax Therapeutics Reports Fiscal Year 2020 Results and Provides Business Update Business Wire
Mar-04-21 08:30AM	Tenax Therapeutics to Present at the H.C. Wainwright Global Life Sciences Virtual Conference Business Wire -10.60%
Mar-02-21 08:15AM	Tenax Therapeutics, Inc. Expands Board of Directors Business Wire
Jan-20-21 10:30AM	TENX: Tenax Picks Up PH Precision Med Zacks Small Cap Research
07:45AM	Tenax Therapeutics Schedules Conference Call to Discuss Its Transformative Acquisition of PH Precision Med Business Wire
Jan-19-21 07:45AM	Tenax Therapeutics, Inc. Announces Transformative Acquisition of PH Precision Med Business Wire +32.58%
Dec-29-20 04:29PM	5 Top Stock Gainers for Tuesday: Snap, Barnes & Noble Education TheStreet.com +85.05%
10:12AM	Benzinga's Top Upgrades, Downgrades For December 29, 2020 Benzinga
Dec-03-20 07:47AM	TENX: FDA Meetings for Phase 3 Design Zacks Small Cap Research +17.14%
Nov-29-20 07:28PM	Is Tenax Therapeutics Inc (TENX) A Good Stock To Buy? Insider Monkey
Nov-16-20 04:45PM	Tenax Therapeutics Reports Third Quarter 2020 Results and Provides Business Update Business Wire
Nov-10-20 08:30AM	Tenax Therapeutics Announces Presentation of 24-Hour HELP Study Results at the American Heart Association Scientific Sessions 2020 Business Wire
Nov-06-20 08:30AM	Tenax Therapeutics to Host Virtual R&D Webinar with Scientific Experts Highlighting HELP Study Results Business Wire +7.80%
Oct-15-20 08:30AM	Tenax Therapeutics Gains North American Rights to Oral Levosimendan through Expanded License Agreement with Orion Corporation Business Wire +8.06%
Oct-02-20 08:30AM	Tenax Therapeutics Announces Late-Breaking Clinical Trial Presentation of Phase 2 HELP Study at Heart Failure Society of America (HFSA) Virtual Annual Scientific Meeting Business Wire
Sep-01-20 10:44AM	Tenax Therapeutics to Present at H.C. Wainwright 22nd Annual Global Investment Conference Business Wire
Aug-31-20 08:30AM	Tenax Announces Late-Breaking Results from the HELP Study Accepted for Presentation at the Heart Failure Society of America (HFSA) Annual Scientific Meeting Business Wire
Aug-28-20 10:54AM	TENX: Upcoming FDA Meetings for Ph3 Design Zacks Small Cap Research
Aug-17-20 08:00AM	Tenax Therapeutics Reports Second Quarter 2020 Results and Provides Business Update Business Wire
Jul-20-20 08:45AM	Tenax Therapeutics Expands Board of Directors with the Appointment of Two New Directors, Steven Boyd and Keith Maher, MD Business Wire
Jul-06-20 07:50PM	Tenax Therapeutics Announces $8.0 Million Registered Direct and PIPE Offerings Priced At-the-Market Under Nasdaq Rules Business Wire
Jun-03-20 09:41AM	Company News for June 3, 2020 Zacks -8.54%
08:30AM	Tenax Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement Business Wire
Jun-02-20 07:30AM	Tenax Therapeutics Reports Positive Results from Phase 2 Trial of Levosimendan in Patients with Pulmonary Hypertension and Heart Failure with Preserved Ejection Fraction (PH-HFpEF) Business Wire +13.10%
Jun-01-20 05:30AM	TENX: Undiscovered Gem Zacks Small Cap Research
May-29-20 01:07PM	Hedge Funds Are Warming Up To Tenax Therapeutics Inc (TENX) Insider Monkey
Apr-13-20 05:55AM	TENX: Full Year 2019 Financial and Operational Review Zacks Small Cap Research
05:40AM	TENX: Full Year 2019 Financial and Operational Review Zacks Small Cap Research
Apr-09-20 08:30AM	Tenax Therapeutics Announces Last Patient Completes Final Visit in its Phase 2 "HELP Study" of Levosimendan for Pulmonary Hypertension and Heart Failure with Preserved Ejection Fraction Business Wire -6.66%
Mar-19-20 10:16AM	Companies Like Tenax Therapeutics (NASDAQ:TENX) Can Be Considered Quite Risky Simply Wall St.
Mar-12-20 08:30AM	Tenax Therapeutics Completes Enrollment in Phase 2 Pulmonary Hypertension Trial Business Wire -36.54%
08:00AM	Tenax Therapeutics Announces $2.75 Million Registered Direct Offering Priced At-the-Market Business Wire
Feb-21-20 08:30AM	Tenax Announces the Addition of Mayo Clinic Expert, Dr. Barry Borlaug, to Scientific Advisory Board Business Wire -5.84%
Jan-21-20 06:15AM	TENX: Enrollment Completion Expected 1Q:20 Zacks Small Cap Research +8.59%
Jan-13-20 08:30AM	Tenax Therapeutics Provides Update on Phase 2 Pulmonary Hypertension Clinical Trial Business Wire -7.91%
Dec-20-19 12:03PM	Does Tenax Therapeutics, Inc. (NASDAQ:TENX) Have A Particularly Volatile Share Price? Simply Wall St.
Nov-04-19 10:45AM	TENX: Tenax HELP Update Zacks Small Cap Research
Oct-31-19 08:00AM	Tenax Therapeutics Provides Update on Phase 2 Pulmonary Hypertension Clinical Trial Business Wire +7.44%
Sep-20-19 03:11PM	We're A Little Worried About Tenax Therapeutics's (NASDAQ:TENX) Cash Burn Rate Simply Wall St.
Sep-12-19 09:15AM	TENX: Focused on the Enrollment Phase Zacks Small Cap Research
Aug-29-19 08:00AM	Tenax Therapeutics to Present at H.C. Wainwright 21st Annual Global Investment Conference Business Wire
Aug-23-19 08:00AM	Tenax Therapeutics Provides Clinical Development Update Business Wire +5.94%
Jul-16-19 12:23PM	What Kind Of Investor Owns Most Of Tenax Therapeutics, Inc. (NASDAQ:TENX)? Simply Wall St.
Jun-12-19 11:25AM	TENX: Screening & Enrollment Continue Zacks Small Cap Research
Apr-11-19 10:15AM	TENX: HELP Trial Enrollment Underway Zacks Small Cap Research
Mar-11-19 03:20PM	Introducing Tenax Therapeutics (NASDAQ:TENX), The Stock That Collapsed 98% Simply Wall St. -10.55%
08:30AM	Tenax Therapeutics Enrolls First Patient for Phase 2 Pulmonary Hypertension Clinical Trial Business Wire
Feb-21-19 01:35PM	Four Biotech Stocks Setting The Standard On Thursday (2/21/19) ACCESSWIRE
Feb-04-19 08:30AM	Tenax Therapeutics to Present at 2019 BIO CEO & Investor Conference Business Wire +5.60%
Jan-04-19 08:30AM	Tenax Therapeutics to Present at Biotech Showcase Investor Conference Business Wire
Dec-11-18 04:00PM	Tenax Therapeutics Announces Closing of $10 Million Underwritten Offering Business Wire -9.02%
Dec-07-18 01:02PM	Tenax Therapeutics Announces Pricing of $10 Million Underwritten Offering Business Wire -17.26%
Nov-26-18 11:00AM	TENX: We Have Liftoff: HELP Site Activated Zacks Small Cap Research -19.69%
Nov-21-18 03:21PM	Heat Biologics Takes Beating After Pricing $12 Million Stock Offering TheStreet.com -19.44%
Nov-19-18 08:00AM	Tenax Therapeutics Activates First Clinical Research Site for Phase 2 Pulmonary Hypertension Clinical Trial Business Wire +5.00%
Nov-07-18 04:20PM	TENX: Tenax S-1 Filing Zacks Small Cap Research -19.06%
Oct-01-18 09:04AM	How Should You Think About Tenax Therapeutics Incs (NASDAQ:TENX) Risks? Simply Wall St. -11.98%
Sep-20-18 08:30AM	Tenax Therapeutics to Present at Upcoming Investor Conferences Business Wire +14.57%
Sep-04-18 10:45AM	TENX: 3Q Start to Pulmonary Hypertension Trial Zacks Small Cap Research
Aug-29-18 08:30AM	Tenax Therapeutics to Present at H.C. Wainwright 20th Annual Global Investment Conference Business Wire
Aug-28-18 08:30AM	Tenax Therapeutics Announces New Clinical Study Publication Results Indicate Levosimendan Offers Renal Protective Benefits to Heart Failure Patients Business Wire
Jun-11-18 07:24PM	Has Tenax Therapeutics Inc (NASDAQ:TENX) Improved Earnings Growth In Recent Times? Simply Wall St.
Jun-07-18 09:30AM	TENX: Tenax 1Q:18 Results Zacks Small Cap Research
Jun-05-18 04:30PM	Tenax Therapeutics Announces Appointment of Anthony A. DiTonno as CEO Business Wire
Jun-04-18 08:37AM	While merger a possibility, Tenax pushes forward with new trial American City Business Journals
Jun-01-18 08:30AM	Tenax Therapeutics Announces Study Design for Phase 2 Trial of Levosimendan in PH-HFpEF Patients Business Wire
May-24-18 02:27PM	Why You Need To Look At This Factor Before Buying Tenax Therapeutics Inc (NASDAQ:TENX) Simply Wall St.
Apr-13-18 12:55PM	How Do Analysts See Tenax Therapeutics Inc (NASDAQ:TENX) Performing In The Next Couple Of Years? Simply Wall St.
Apr-12-18 10:10AM	TENX: New Indication for Levosimendan Zacks Small Cap Research
Apr-06-18 01:36PM	Finding Breakouts And Avoiding Fakeouts In A Market At War With Itself Benzinga
08:21AM	Amid strategic review, Tenax gets go-ahead from FDA American City Business Journals
Apr-05-18 02:43PM	Benzinga's Top Analyst Calls From April 5, 2018 Benzinga
08:05AM	This $3 Medical Device Stock be Worth $9-14 with Impending Product Launch ACCESSWIRE
Apr-04-18 10:23AM	Tenax Therapeutics Incs (NASDAQ:TENX) Shift From Loss To Profit Simply Wall St.
08:00AM	Tenax Therapeutics Announces Results of Pre-IND Meeting with FDA for Phase 2 Study of Levosimendan in PH-HFpEF Patients Business Wire
Mar-14-18 08:00AM	Tenax Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement Business Wire
Mar-08-18 02:11PM	With A -97.88% Earnings Drop Lately, Did Tenax Therapeutics Inc (NASDAQ:TENX) Underperform Its Industry? Simply Wall St.
Mar-02-18 08:10AM	Todays Research Reports on Stocks to Watch: Novavax and Tenax Therapeutics ACCESSWIRE
Mar-01-18 08:30AM	Tenax Therapeutics Announces New Scientific Publication of Preclinical Data Provides Additional Evidence of Levosimendan Treatment Effects in Pulmonary Hypertension Business Wire
Feb-23-18 08:00AM	Tenax Therapeutics Announces Reverse Stock Split Business Wire
Feb-06-18 08:30AM	World-Recognized Experts Join Tenax Therapeutics Scientific Advisory Board to Guide New Phase 2 Study Business Wire
Jan-16-18 07:45AM	Tenax Therapeutics Announces Plan to Develop Levosimendan for a Pulmonary Hypertension Indication with No FDA Approved Therapies Business Wire
Jan-02-18 08:09PM	Does Zero-Debt Make Tenax Therapeutics Inc (NASDAQ:TENX) A Financially Strong Company? Simply Wall St.
Aug-02-17 07:00AM	TENX: FDA Response on Levosimendan Zacks Small Cap Research
Jul-28-17 05:00PM	Tenax Therapeutics Provides Regulatory Update on Levosimendan Business Wire
May-16-17 04:33PM	Tenax Meets with FDA to Discuss Positive Mortality Data and Potential Levosimendan NDA Submission Business Wire
Apr-10-17 03:25PM	Tenax CEO resigns, company to review 'strategic alternatives' American City Business Journals
Apr-05-17 05:30PM	Tenax Therapeutics Announces Review of Strategic Alternatives and Business Update Business Wire
Mar-27-17 09:00AM	TENX: 2016 Results; Subgroup Analysis Shows CABG Survival Benefit Zacks Small Cap Research
Mar-22-17 01:04PM	TENAX THERAPEUTICS, INC. Financials
Mar-21-17 07:07AM	Q4 2016 Tenax Therapeutics Inc Earnings Release - Before Market Open
06:00AM	Tenax Therapeutics Announces Year-End 2016 Financial Results and Provides Corporate Update Business Wire
Mar-20-17 04:05PM	Investor Network Invites You to the Tenax Therapeutics Fiscal Year 2016 Business Review and Update Conference Call and Webcast on Tuesday, March 21, 2017 Accesswire
Mar-17-17 05:02PM	TENAX THERAPEUTICS, INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or St
Mar-16-17 04:34PM	TENAX THERAPEUTICS, INC. Files SEC form 10-K, Annual Report
Mar-15-17 04:31PM	Tenax Therapeutics to Discuss Year-End 2016 Financial Results and Provide Business Update Business Wire

Tenax Therapeutics, Inc., a specialty pharmaceutical company, engages in identifying, developing, and commercializing products for cardiovascular and pulmonary diseases in the United States and Canada. The company develops levosimendan, which completed a phase II clinical trials for the treatment of patients with pulmonary hypertension associated with heart failure with preserved ejection fraction; and Imatinib, a tyrosine kinase inhibitor for the treatment of pulmonary arterial hypertension. The company was formerly known as Oxygen Biotherapeutics, Inc. and changed its name to Tenax Therapeutics, Inc. in September 2014. Tenax Therapeutics, Inc. was founded in 1967 and is headquartered in Morrisville, North Carolina.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
ARMISTICE CAPITAL, LLC	Director	Sep 08	Buy	1.46	8,543	12,473	2,019,995	Sep 09 07:04 PM
ARMISTICE CAPITAL, LLC	Director	Sep 04	Buy	1.41	23,457	33,074	2,011,452	Sep 09 07:04 PM
ARMISTICE CAPITAL, LLC	Director	Sep 03	Buy	1.39	36,000	50,040	1,987,995	Sep 03 05:39 PM
ARMISTICE CAPITAL, LLC	Director	Sep 02	Buy	1.47	20,000	29,400	1,951,995	Sep 03 05:39 PM
ARMISTICE CAPITAL, LLC	Director	Sep 01	Buy	1.46	30,000	43,800	1,931,995	Sep 03 05:39 PM
ARMISTICE CAPITAL, LLC	Director	Aug 31	Buy	1.45	20,000	29,000	1,901,995	Aug 31 07:38 PM
ARMISTICE CAPITAL, LLC	Director	Aug 27	Buy	1.50	12,000	18,000	1,881,995	Aug 31 07:38 PM
ARMISTICE CAPITAL, LLC	10% Owner	Aug 26	Buy	1.50	12,000	18,000	1,869,995	Aug 26 05:47 PM
ARMISTICE CAPITAL, LLC	10% Owner	Aug 25	Buy	1.53	17,211	26,333	1,857,995	Aug 26 05:47 PM
ARMISTICE CAPITAL, LLC	10% Owner	Aug 24	Buy	1.47	5,692	8,367	1,840,784	Aug 26 05:47 PM
ARMISTICE CAPITAL, LLC	Director	Aug 21	Buy	1.44	116,242	167,388	1,835,092	Aug 21 05:56 PM
ARMISTICE CAPITAL, LLC	Director	Aug 20	Buy	1.53	124,472	190,442	1,718,850	Aug 21 05:56 PM
ARMISTICE CAPITAL, LLC	Director	Aug 19	Buy	1.45	70,767	102,612	1,594,378	Aug 21 05:56 PM
BLANCK RONALD R	Director	May 18	Buy	0.95	5,000	4,774	6,062	May 19 04:31 PM

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience